Dan Dolan | Chief Financial Officer |
Ted Schroeder | Chief Executive Officer |
Steve Gelone | President and Chief Operating Officer |
Carl Byrnes | Northland Capital |
Good day, and welcome to the Nabriva Therapeutics Fourth Quarter 2021 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions] As a reminder, this call may be recorded. I would like to turn the call over to Dan Dolan, Nabriva's Chief Financial Officer.